WELLSCARE CO., LTD – Trademark Portfolio

Entity Type: 99

WELLSCARE CO., LTD holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include IASO. The owner is based in Seoul.

(Yeoksam-dong), 5F

342, Gangnam-daero, Gangnam-gu

Seoul 06242 , KR

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IASO
IASO
Abandoned 2019
IASO
IASO
Registered 2019
EPIONE
EPIONE
Abandoned 2019

Trademark Classifications

WELLSCARE CO., LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does WELLSCARE CO., LTD have?

WELLSCARE CO., LTD has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.

What trademark classes does WELLSCARE CO., LTD file in?

WELLSCARE CO., LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are WELLSCARE CO., LTD's most well-known trademarks?

WELLSCARE CO., LTD's registered trademark portfolio includes well-known marks such as IASO. These are among 1 currently registered trademark in the portfolio.

What is WELLSCARE CO., LTD's trademark registration success rate?

WELLSCARE CO., LTD has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.